Medherant | Medherant is creating a sustainable, next-generation transdermal drug delivery patch company that creates value for patients, partners and investors.

Developing innovative transdermal drug delivery patches for women’s health, pain and CNS diseases

TEPI Patch^® technology offers greater convenience, confidence and comfort for patients.

News & Events

News & Media

Notice of US patent allowance

September 6, 2024

Preliminary results of clinical study of Medherant’s testosterone patch for post-menopausal women

April 10, 2024

Upcoming events

There are currently no upcoming events.

Our partners

For development of products for transdermal or topical delivery using our TEPI patch technology, contact us.